-

Retractable Technologies, Inc. Reports Change to Meeting Date

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) (the “Company”) today announced that, due to the public health impact of the coronavirus (COVID-19) pandemic, and related health and travel concerns, the date of the 2020 annual meeting of shareholders of Retractable Technologies, Inc. (the “Annual Meeting”) has been changed to June 22, 2020 at 10:00 a.m. The adjourned meeting is expected to be held at Little Elm Town Hall located at 100 West Eldorado Parkway, Little Elm, Texas 75068. However, the Company has also secured a vendor to assist in facilitating a virtual meeting on June 22, 2020 if an in-person meeting is still not advisable due to COVID-19 concerns. If the format of the meeting is changed to a virtual meeting, a notice will be distributed by press release.

A notice regarding the change to the date of the Annual Meeting (the “Notice”) is being filed with the Securities and Exchange Commission together with this press release. Additional information regarding the Annual Meeting, shareholder participation and voting is provided in the Notice.

The Company manufactures and markets VanishPoint® and Patient Safe® safety medical products and the EasyPoint® needle. The VanishPoint® syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe® syringes are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint® is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint® needle also can be used to aspirate fluids and for blood collection. The Company’s products are distributed by various specialty and general line distributors.

For more information on Retractable Technologies, Inc., visit its website at www.retractable.com.

Contacts

Retractable Technologies, Inc.
John W. Fort III, 888-806-2626 or 972-294-1010
Vice President and Chief Financial Officer

Industry:

Retractable Technologies, Inc.

NYSEAM:RVP
Release Versions
English

Contacts

Retractable Technologies, Inc.
John W. Fort III, 888-806-2626 or 972-294-1010
Vice President and Chief Financial Officer

More News From Retractable Technologies, Inc.

Retractable Technologies, Inc. Results for the Period Ended March 31, 2026

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports total net sales of $7.2 million for the first three months of 2026 and an operating loss of $6.2 million for the period, as compared to total net sales for the same period last year of $8.3 million and an operating loss of $4.7 million. In the first quarter of 2026, a larger proportion of international sales and an increase in EasyPoint® needle sales contributed to lower overall revenues despite unit...

Retractable Technologies, Inc. Announces Workforce Reduction

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports that it has reduced its workforce by approximately 16%. The reduction is expected to save an estimated $2.2 million in annual wages and employment benefits, or approximately 13% of total estimated workforce costs. The expected savings are offset by estimated one-time separation payments of approximately $122 thousand to the affected workers. Approximately 58% of the targeted payroll reduction affects...

Retractable Technologies, Inc. Reports Results for 2025

LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE American: RVP) reports the following information relating to the year ended December 31, 2025. Further details concerning the results of operations as well as other matters are available in Retractable’s Form 10-K filed on March 27, 2026 with the U.S. Securities and Exchange Commission. The Company’s revenues for 2025 increased 15.8%. The Company’s revenues were approximately $38.3 million in 2025 as compared to approximat...
Back to Newsroom